Apotex Dodges Horizon Patent Suit Over Generic Pennsaid
A Delaware federal judge has cleared pharmaceutical maker Apotex in rival Horizon's patent suit over a generic version of anti-inflammatory drug Pennsaid, ruling that Apotex's agreement with a different licensor grants...To view the full article, register now.
Already a subscriber? Click here to view full article